ToxSci Advance Access originally published online on March 14, 2006
Toxicological Sciences 2006 91(2):476-483; doi:10.1093/toxsci/kfj153
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mitochondrial and Nuclear DNA Damage Induced by Curcumin in Human Hepatoma G2 Cells
* Department of Toxicology, College of Laboratory Medicine, and Department of Microbiology, Dalian Medical University, Dalian 116027, China; and Laboratory of Pharmaceutical Resource Discovery, Dalian Institute of Chemical Physics, the Chinese Academy of Sciences, Dalian 116023, China
1 To whom correspondence should be addressed at Department of Toxicology, Dalian Medical University, 465 Zhongshan Road, Dalian 116027, China. Fax: +86 411 8472 0661. E-mail: rdrczhong{at}dlmedu.edu.cn.
Received November 18, 2005; accepted March 2, 2006
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONSUPPLEMENTARY DATAREFERENCES |
|---|
Curcumin is extensively used as a spice and pigment and has anticarcinogenic effects that could be linked to its antioxidant properties. However, some studies suggest that this natural compound possesses both pro- and antioxidative effects. In this study, we found that curcumin induced DNA damage to both the mitochondrial and nuclear genomes in human hepatoma G2 cells. Using quantitative polymerase chain reaction and immunocytochemistry staining of 8-hydroxydeoxyguanosine, we demonstrated that curcumin induced dose-dependent damage in both the mitochondrial and nuclear genomes and that the mitochondrial damage was more extensive. Nuclear DNA fragments were also evident in comet assays. The mechanism underlies the elevated level of reactive oxygen species and lipid peroxidation generated by curcumin. The lack of DNA damage at low doses suggested that low levels of curcumin does not induce DNA damage and may play an antioxidant role in carcinogenesis. But at high doses, we found that curcumin imposed oxidative stress and damaged DNA. These data reinforce the hypothesis that curcumin plays a conflicting dual role in carcinogenesis. Also, the extensive mitochondrial DNA damage might be an initial event triggering curcumin-induced cell death.
Key Words: curcumin; DNA damage; mitochondrial DNA; nuclear DNA; quantitative polymerase chain reaction; HepG2 cells.
|
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONSUPPLEMENTARY DATAREFERENCES |
|---|
Cancer mortality rates have risen throughout most of the past century and into the new millennium (Greenlee et al., 2000
). Cancer is already the leading cause of death in some countries (Tattersall and Thomas, 1999). This observation has engendered much research activity aimed at identifying cancer chemopreventive agents, especially naturally occurring compounds derived from the diet, which have the advantage of being relatively nontoxic (Jobin et al., 1999). However, limited scientific evidence regarding the effectiveness of these natural derivatives in conjunction with a lack of mechanistic understanding of their actions have prevented their entry into the mainstream of medical care.
Curcumin (diferuloylmethane or 1,7-bis (4-hydroxy-3-methoxyphenol)-1,6-heptadiene-3,5-dione) is a natural compound present in turmeric, a rhizome of the plant Curcuma longa Linn. It is extensively used as a dietary spice and pigment in Asian cooking and also as an herbal medicine for inflammatory diseases. In certain countries, curcumin was consumed in the diet in amounts in excess of 100 mg/day without any side effects (Ammon and Wahl, 1991). Also in some other countries, up to 4 g per adult/day appears to lower the incidence rate of colorectal cancer (Sharma et al., 2001). Further studies show that curcumin prevents cancer in many tissues of mice and rats and has been associated with regression of established solid malignancies in humans (Kuttan et al., 1987; Plummer et al., 2001). However, the mechanisms of action for curcumin are not well understood. Contradictory results have been obtained. For example, the antioxidant properties of curcumin are well established. In cellular experiments, curcumin suppressed the generation of reactive oxygen species (ROS) and protected against DNA damage induced by benz(a)pyren or H2O2 (Polasa et al., 2004). On the other hand, curcumin can apparently act as a prooxidant. In human peripheral blood lymphocytes, curcumin itself resulted in ROS that damage DNA (Kelly et al., 2001).
However, with regard to DNA damage, few studies have looked into the effect of curcumin on mitochondrial DNA (mtDNA). The 16-kb mitochondrial genome has been fully sequenced and encodes for only 13 proteins involved in the electron transport chain of oxidative phosphorylation (Linnane et al., 1989). Depletion of the mtDNA reduces oxidative phosphorylation, decreases ATP synthesis, and induces dysfunction of the mitochondria. Mutations in mtDNA have been associated with aging, carcinogenic processes, and with several diseases such as neuronal degeneration and cardiovascular disease (Bandy and Davison, 1990). The mtDNA is also more susceptible to ROS compared to nuclear DNA (nDNA) and consequently is more prone to oxidative injury than the nDNA (Onuki et al., 2004; Yakes and Van Houten, 1997).
The purpose of this study was to examine the effects of curcumin on both mtDNA and nDNA in human hepatoma G2 (HepG2) cells, a cell line that retains many characteristics of hepatocytes such as the activities of phase I and phase II enzymes that play key roles in the activation and detoxification of DNA-reactive carcinogens. Therefore, HepG2 cells reflect the metabolism of xenobiotics in the human body better than other metabolically incompetent cells (Mersch-Sundermann et al., 2004), and they are a relevant in vitro model to evaluate the possible mitochondrial toxicity of newly developed drugs in liver cells and to examine a drug's interaction with liver functions (Sassa et al., 1987).
We are the first to evaluate the damage to nDNA and mtDNA induced by curcumin in the metabolically competent HepG2 cells. Using quantitative polymerase chain reaction (QPCR) and immunocytochemistry staining of 8-hydroxydeoxyguanosine (8-OHdG), we found that curcumin induced damage to both the mitochondrial and nuclear genomes in a dose-dependent manner and that the damage to mtDNA appeared more extensive than that of nDNA. The alkaline comet assay was used to determine nDNA fragmentation. As the conceivable cause of DNA damage, the level of ROS and lipid peroxidation were analyzed. Our data suggested that low doses of curcumin did not damage DNA, and at the low doses, curcumin could play an antioxidant role in carcinogenesis. But at high doses, curcumin itself imposed oxidative stress and damaged DNA. This study helps support the hypothesis that curcumin may play a conflicting dual role in carcinogenesis according to its doses. We also concluded that the extensive mtDNA damage may be an initial event triggering the observed curcumin-induced cell death.
|
MATERIALS AND METHODS |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONSUPPLEMENTARY DATAREFERENCES |
|---|
Cell culture and reagents.
HepG2 cells (American Type Culture Collection (ATCC) HB-8065) were obtained from Peking Union Medical College (Peking, China) and cultured in minimum essential Eagle's medium (ATCC) containing 10% fetal bovine serum (Gibco, Grand Island, NY), penicillin (100 units/ml, Gibco), and streptomycin (100 µg/ml, Gibco). Curcumin was purchased from Xi'an Chongxin Natural Additives Co. Ltd. (Xi'an, China; purity > 95.6%). Curcumin was prepared as a 4-mg/ml stock solution in dimethyl sulfoxide (DMSO, Sigma, Louis, MO) and stored at –20°C. For each experiment, curcumin was diluted with cell culture medium to the concentration indicated with a final DMSO concentration of 1% (vol/vol). Two vehicles of culture medium with or without 1% DMSO were included in all subsequent experiments. In each experiment there was no difference between these controls; thus, we usually employed culture medium with 1% DMSO as the control for comparison.
Cell viability assay.
Cell viability was assessed by the methyl thiazol tetrazolium bromide (MTT) assay as described previously (Mosmann, 1983). HepG2 cells were plated in a 96-well microtiter plate at a density of 1 x 104 cells per well in a final volume of 100 µl modified Eagle medium (MEM). The cells were treated with curcumin (2.5, 5, 10, 20, and 40 µg/ml) for 24, 48, and 72 h. After treatment, the cells were incubated with MTT solution (5 mg/ml) for 2 h at 37°C. The formazan crystals formed were dissolved in DMSO at 37°C for 1 h in the dark, and the absorbance was read at 595 nm in a microplate reader (BIO-RAD Model 3550).
DNA extraction and QPCR.
HepG2 cells (1 x 106) were plated 24 h before treatment. Monolayer cultures were exposed to the indicated concentrations of curcumin for 2 h at 37°C. Cells were harvested immediately by trypsin (0.25% trypsin in phosphate-buffered saline [PBS] with 0.02% ethylenediaminetetraacetic acid [EDTA], Gibco). High–molecular weight DNA was isolated with the QIAamp DNA Micro kit (Qiagen, Hilden, Germany) as described by the manufacturer. DNA isolated by this technique has been shown to be suitable for QPCR (Onuki et al., 2004). The DNA quantity was determined at 260 nm using an ultrospectrophotometer (Ultrospec II, LKB Biochrom, Cambridge, UK). The DNA samples were adjusted to a concentration of 0.5 mg/ml.
By examining a wide variety of DNA-damaging agents, QPCR assay has been proved to be quite robust for detecting both mtDNA and nDNA damage (Mandavilli et al., 2005; Velsor et al., 2004). This technique is based on the premise that DNA lesions, including oxidative damage such as strand breaks, base modifications, and abasic sites, will block the progression of the polymerase, resulting in a decrease in amplification of a target sequence (Yakes et al., 1996), and only those DNA templates that do not contain polymerase-blocking lesions will be amplified. Thus, amplification is inversely proportional to DNA damage: the more lesions on the target DNA, the less the amplification. QPCR was performed as described by Yakes and Van Houten (1997), briefly in 50 µl volumes with the LA PCR Kit Ver. 2.1 (Takara, Dalian, China) using GeneAmp PCR System 2400 (Perkin-Elmer, Wellesley, MA). The reaction mixtures contained 2 µl template DNA, 5 µl 10 x LA PCR Buffer (Mg2+ plus), 8 µl deoxynucleoside triphosphate (dNTP) mixture, 1 µl of each primer, and 0.5 µl TaKaRa LA Taq. The primer nucleotide sequences were as follows: for the 16.2-kb fragment of the mitochondrial genome, 5'-TGAGGCCAAATATCATTCTGAGGGGC-3' (RH1065) and 5'-TTTCATCATGCGGAGATGTTGGATGG-3' (RH1066) (Yakes and Van Houten, 1997); and for the 17.5-kb flanking region of the ß-globin gene (GenBank data base accession number, NT 009237), 5'-ACATGATTAGCAAAAGGGCCTAGCTTGGACTCAGA-3' (bases 783–818), and 5'-TGCACCTGCTCTGTGATTATGACTATCCCACAGTC-3' (bases 18357–18391).
The PCR was initiated at 75°C with hot-start addition of the polymerase and allowed to undergo the following thermocycler profile: an initial denaturation for 1 min at 94°C followed by 30 cycles of 98°C denaturation for 20 s and 68°C annealing and extension for 15 min. A final extension at 72°C was performed for 10 min. To ensure quantitative conditions, control reactions containing 50% control templates were included with each amplification. The reaction products were electrophoresed on a 0.8% agarose/TBE (Tris-borate-EDTA) gel containing ethidium bromide (1 µg/ml) at 120 V for 60 min. The amplified products were visualized on gels and quantitated with LabWorks (ver 4.6, UVP, BioImaging Systems, Upland, CA). Amplification of treated samples was then compared with controls, and the relative amplification was calculated. DNA lesion frequencies were also calculated as follows (Yakes and Van Houten, 1997). The amplification of damaged samples (AD) was normalized to the amplification of nondamaged controls (AO), resulting in a relative amplification ratio. Assuming a random distribution of lesions and using the Poisson equation [
where 
is the average lesion frequency] for the control templates (i.e., the zero class; x = 0), the average lesion frequency per DNA strand was determined as = lnAD/AO.
Immunocytochemistry staining for 8-OHdG.
An immunoperoxidase method using a monoclonal 8-OHdG antibody has been developed for detection and quantitation of oxidative damage in single cells (Yarborough et al., 1996). Using this method we detected 8-OHdG in both mtDNA and nDNA in situ, eliminating the need for isolation of DNA (Xu et al., 1999). Exponentially growing cells were seeded onto coverslips in 12-well tissue culture plates at 1 x 105 cells and cultured for 24 h. Cells were treated with curcumin for 2 h at 37°C. H2O2 (20µM) was used as a positive control. After treatment, cells were rinsed twice with PBS and fixed with cold acetone for 10 min. To avoid detecting 8-OHdG incorporated into RNA, the fixed cultures were treated with RNase (100 µg/ml) for 1 h at 37°C. DNA was denatured for 5 min at 4°C and treated with 0.1% Triton X-100 for 5 min at 4°C. To block nonspecific antibody binding sites, 10% normal horse serum was used, and the cells were incubated with the primary antibody (JaICA, Fukuroi, Japan) in PBS (1:200) at 4°C overnight. Subsequently, using Ultrasensitive Streptavidin-peroxidase Kit (Maixin-Bio, Fujian, China), the cells were rinsed and biotin-conjugated secondary antibody was added for 30 min at room temperature, rinsed with PBS three times and streptavidin-peroxidase for 10 min at room temperature. Diaminobenzidene was applied as color presentation (3–10 min). For measurement of 8-OHdG of mtDNA, the cells were counterstained for nuclei with hematoxylin. The images were taken by microscope (Olympus BX-51, Omachi, Japan), and multiparameter image analysis software Image-pro plus 4.5.1 was used to quantify the staining intensity from 50 randomly selected cells per group per experiment. Staining data represent the average absorbance multiplied by 1000.
Comet assay.
To detect cellular DNA damage as single-strand breaks, comet assay was performed as described by Singh and Stephens (1997). HepG2 cells (1 x 106 cells) were suspended in 2 ml MEM and incubated with curcumin (0, 2.5, 5, 10, 20, and 40 µg/ml) at 37°C for 1 h. H2O2 (20µM) was used as a positive control. After washing twice with PBS, the cells were suspended in 1 ml PBS. To avoid artifacts resulting from necrotic and apoptotic cells, the cell suspensions (50 µl) were mixed with Hoechst 33342 (8 µg/ml) and propidium iodide (50 µg/ml). After incubation in the dark for 15 min, the necrosis and apoptosis were identified under a fluorescent microscope (U-MWU2 filters). Only cell suspensions with no apoptotic cells and cell viabilities > 90% were used for determination of DNA fragments. Twenty microliters of the cell suspension was mixed with 160 µl of 0.6% low-melting agarose and placed on frosted slides prelayered with 1% regular agarose. After solidification of low-melting agarose, the slides were immersed in lysing solution (2.5M NaCl, 100mM EDTA, 10mM Tris, pH 10, and 1% sodium sarcosinate with 1% Triton X-100) at 4°C for 1 h. After the lysis, the slides were placed in alkaline solution (1mM Na2EDTA and 300mM NaOH, pH 13) for 20 min to allow DNA unwinding, and then they were electrophoresed for 30 min at 200 mA. Cells were neutralized using 0.4M Tris (pH 7.5) and stained with 50 µl ethidium bromide (20 µg/ml). Slides were viewed at x400 magnification using fluorescent microscopy with an excitation filter of 549 nm and barrier filter of 590 nm. Comets were quantitatively analyzed using Comet Assay Software Project casp-1.2.2 (University of Wroclaw, Poland). Each treatment was carried out in duplicate, and 100 randomly selected comets from two microscope slides were analyzed.
Measurement of intracellular ROS.
The production of ROS was measured using the 2,7-dichlorofluorescein diacetate (DCFH-DA) method (Sohn et al., 2005). DCFH-DA penetrates the cells and is hydrolyzed by intracellular esterases to the nonfluorescent DCFH, which can be rapidly oxidized to the highly fluorescent 2,7-dichlorofluorescein (DCF) in the presence of ROS. Myhre et al. (2003) reported that DCFH-DA was more sensitive to H2O2 than other ROS. As curcumin is known to possess fluorescent properties, all our ROS experiments were corrected with the appropriate control sample containing only curcumin. HepG2 cells (5 x 105) were suspended in 2 ml medium and were incubated with curcumin (0, 2.5, 5, 10, 20, and 40 µg/ml) at 37°C for 1 h. H2O2 (20µM) was used as a positive control. Cells were washed twice with cold PBS, suspended in PBS at 5 x 105 cells/ml, and loaded with DCFH-DA at a final concentration of 5µM and incubated for 40 min at 37°C in the dark. The fluorescent intensity of the cell suspensions was detected using a fluorescence spectrophotometer (HITACHI 650-60, Tokyo, Japan). Excitation and emission wavelengths were 485 and 550 nm, respectively. The results were expressed as fluorescent intensity per 1 x 106 cells.
Lipid peroxidation assay.
Lipid peroxidation was determined by measurement of thiobarbituric acid–reactive substances (TBARS) formed during the decomposition of lipid hydroperoxides (Leal et al., 2005). After exposure to increasing concentrations of curcumin for 2 h, the cells (5 x 104) were lysed with Triton X-100. The lysed cells (250 µl) were placed into glass tubes and incubated in a water bath at 37°C for 1 h and followed by the addition of 400 µl 35% perchloric acid. Mixtures were centrifuged at 5000 x g for 10 min at room temperature, and 200 µl of 1.2% thiobarbituric acid was added to the supernatants (600 µl) and then placed in a boiling water bath for 30 min. After cooling, the absorbance was measured at 535 nm with BIO-RAD microplate reader Model 3550.
Statistical analysis.
Results are expressed as means and SDs. Statistical analyses were performed with Student's t-test. Differences were considered statistically significant when p < 0.05.
|
RESULTS |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONSUPPLEMENTARY DATAREFERENCES |
|---|
Curcumin Inhibits the Growth of HepG2 Cells in a Concentration- and Time-Dependent Manner
The growth inhibition by curcumin in HepG2 cells was observed after incubation for 24 h, and the maximum growth inhibitory effects with curcumin were observed at 72 h (Fig. 1). Curcumin presented strong cytotoxic effects at concentrations above 20 µg/ml. The resulting growth curves showed that the inhibition was concentration and time dependent. The IC50 (inhibitory concentration 50%) values for 24, 48, and 72 h were 31.29 ± 0.90 µg/ml, 22.36 ± 1.45 µg/ml, and 16.43 ± 1.81 µg/ml, respectively.
|
Curcumin Leads to Dose-Dependent DNA Damage to both mtDNA and nDNA Detected by QPCR
QPCR was performed to detect polymerase-blocking lesions, such as abasic sites, strand breaks, and several damaged bases, including those generated by oxidative and alkylative damage. Thus, any decreased amplification of a damaged DNA template should be due to the blocking of Taq polymerase by DNA lesions and not the exhaustion of a critical reagent. For this to be the case, amplifications must be performed at a cycle number that is within the exponential phase of the PCR. This ensures that other components of the reaction, such as dNTPs, primers, or Taq polymerase, are not limiting. To further ensure that the limiting factor for amplification was nondamaged template availability, the amount of nondamaged template was titrated from 0.0625 to 1.0 µg to ensure that amplification signal was linearly related to the amount of nondamaged template (data not shown).
As shown in Figure 2, a 2-h exposure of HepG2 cells to curcumin led to a dose-dependent decrease in the amplification of both mtDNA and nDNA. Reduction in amplification of the mitochondrial genome occurred at significantly lower doses of curcumin (5 µg/ml) than for the nDNA (20 µg/ml curcumin). Damage to both genomes appeared to plateau at a higher concentration of curcumin. These data suggested that the curcumin-induced damage to mtDNA was more extensive than its damage to nDNA.
|
8-OHdG Content Increased in Both mtDNA and nDNA at All Tested Concentrations
8-OHdG is the most widely measured oxidative damage to mtDNA as well as nDNA (Hayakava et al., 1992
; Richter, 1995). In the present study, we employed an immunocytochemical approach using a monoclonal antibody against 8-OHdG to detect the 8-OHdG in situ in nuclei for nDNA damage and in the cytoplasm for mtDNA damage. H2O2 treatment to cells was used as a positive control for 8-OHdG formation. Our results showed that H2O2 treatment caused a significant increase (p < 0.01) in the staining intensity of 8-OHdG in HepG2 cells (data not shown). Figure 3 shows representative immunocytochemical staining for 8-OHdG in HepG2 cells with or without curcumin treatment. These results indicated that 8-OHdG staining was positive in both the nDNA and the mtDNA at all tested curcumin concentrations. As curcumin concentration increased, the staining intensity of 8-OHdG increased more in the mtDNA than in the nDNA, giving a 15-fold increase in 8-OHdG staining in mtDNA between 40 µg/ml and control compared to a 6-fold increase in nDNA staining. In agreement with our QPCR data, these results showed that the oxidative damage was more significant in mtDNA than in nDNA of HepG2 cells treated with curcumin.
|
Curcumin Induced nDNA Strand Breaks in HepG2 Cells
Comet assay, also called single-cell gel electrophoresis, allows detection of DNA fragments resulting from a wide variety of DNA damage (Uhl et al., 2000
). Using costaining with propidium iodide and Hoechst 33342, cell viability and any apoptosis were measured at the same time. In all groups, no apoptotic cells were observed, and the cell viabilities were more than 90% (data not shown). Thus, all cells observed were used for determining DNA damage. In the positive control group (H2O2 treated), a significant increase in tail moment (105.1 ± 5.8 µm, p < 0.01) was observed. As shown in Figure 4, curcumin increased the DNA migration in a dose-dependent manner. The presence of comet tails was evident after HepG2 cells were incubated with only 2.5 µg/ml curcumin, and the comet tail moment values increased by 9.3 µm (from 4 µm for the negative controls to 13.3 µm). More pronounced comets were detected in cells that had been incubated with 5 µg/ml curcumin (tail moment: 29.2 µm). Within the concentrations ranging from 10 to 40 µg/ml, there was a significant increase in the comet tail moment values from 59.1 to 334 µm, exceeding over 10, 30, and 80 times, compared to the nontreated cells. HepG2 cells that had been incubated with 40 µg/ml curcumin showed comets without heads and only tails, indicating much more extensive DNA damage by single-strand breaks (Table 1).
|
|
ROS Generated in HepG2 Cells Treated with High Concentrations of Curcumin
In this study, we employed DCFH-DA to measure intracellular generation of ROS. As a positive control, HepG2 cells were treated with H2O2. The DCF fluorescence intensity of this H2O2-treated group increased nearly threefold compared with the untreated control (data not shown). There was no increase in intracellular level of ROS after the 1-h incubation with 2.5 µg/ml curcumin (p > 0.05) compared to untreated. When the concentrations of curcumin were raised to 5 and 10 µg/ml, the level of ROS was significantly elevated (p < 0.05). The DCF fluorescence intensity increased further when the HepG2 cells were treated with 20 and 40 µg/ml curcumin (p < 0.001) compared to untreated. This dose response demonstrated that curcumin had a strong effect on ROS production (Fig. 5).
|
Treatment with Curcumin Increased Lipid Peroxidation in HepG2 Cells
Lipid peroxidation is the result of interactions between free radicals of diverse origins and unsaturated fatty acids and lipids. In this study, lipid peroxidation was determined by measurement of TBARS. In the positive control group (H2O2 treated), the TBARS absorbance increased twofold (data not shown). An increase in TBARS formation did not occur at the lower concentrations of curcumin (2.5 and 5 µg/ml). But TBARS formation significantly increased at higher concentrations of curcumin compared to negative control (p < 0.01; Fig. 6).
|
|
DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONSUPPLEMENTARY DATAREFERENCES |
|---|
This is the first report of curcumin inducing DNA damage in both nuclear and mitochondrial genomes in HepG2 cells. HepG2 cells are suitable for detecting cytotoxic and genotoxic substances owing to their endogenous expression of a variety of antioxidant and xenobiotic-metabolizing enzymes. They are of great relevance to be a tool for chemical risk assessment (Mersch-Sundermann et al., 2004
). The results of QPCR demonstrated that curcumin led to DNA damage in both the nuclear and mitochondrial genomes in a dose-dependent manner. Curcumin-induced mtDNA damage appeared more extensive than that of the nDNA.
As a marker of oxidative DNA damage, 8-OHdG was detected using immunocytochemistry staining in both mtDNA and nDNA. 8-OHdG, constituting 10% of the total base adducts, is just one out of many lesions produced by ROS in DNA. However, it is the most widely used method to detect mtDNA oxidative modification because 8-OHdG is usually more abundant in oxidative damage in mtDNA than in nDNA (Hayakava et al., 1992). The data of our study showed that 8-OHdG increased more significantly in the mtDNA than that of the nDNA, consistent with our QPCR results.
The vulnerability of the mitochondrial genome to oxidative damage could be due to many factors, including: (1) the absence of histones or DNA-binding proteins (Shoffner and Wallace, 1994); (2) having only a very basic repair mechanism (Croteau et al., 1999); (3) genes consisting only of exons without introns; (4) replicating rapidly without a significant proofreading system; and (5) a mutation rate 10–100 times higher than that of nDNA (Kao et al., 1998).
It is also known that mtDNA is more prone to oxidative damage as it is in closer contact to the ROS produced in the mitochondria. Lipids within the mitochondrial membrane contain components of the electron transport chain, and lipid peroxidation has been shown to be one potential source of continued DNA damage (Hruazkewycz, 1988). Secondary ROS reactions have the potential of overwhelming the repair capacity of the mitochondrion and can lead to persistent DNA damage.
Therefore, we investigated the level of ROS and lipid peroxidation in HepG2 cells treated with curcumin. Our results provided support for the role of ROS and secondary ROS produced by lipid peroxidation in mtDNA damage. It inferred that ROS and lipid peroxidation generated directly or indirectly by curcumin underlies the mechanism of curcumin-induced DNA damage.
Comet assays also clearly showed that curcumin at high dosages can induce nDNA damage in HepG2 cells. Our data are in agreement with results obtained in gastric mucosa cells and human peripheral blood lymphocytes (Blasiak et al., 1999).
The damage to mtDNA is potentially more important than the damage to nDNA (Liang and Godley, 2003) because the genes coded by the mitochondrial genome are all expressed while nDNA contains a large amount of nontranscribed sequence. At the same time, mtDNA, unlike nDNA, is continuously replicated. Also, the mitochondrial genome codes essential components of the oxidative phosphorylation machinery, providing energy for every cell function. Hence, mtDNA damage potentially causes more adverse effects on cellular functions than does nDNA damage.
There are several hypotheses stating that mtDNA mutations could amplify the nDNA lesions, increase the probability of oncogene activation or tumor suppressor genes inactivation, and contribute to cellular aging and promotion of cancer (Bandy and Davison, 1990). So, curcumin-induced DNA damage in mtDNA and nDNA could both contribute to the carcinogenic process.
Curcumin is usually considered as a potent antioxidant, primarily because it is able to inhibit ROS generation and decrease lipid peroxidation (Chan et al., 2005). In our study, curcumin at low doses had no effect on DNA damage, which does not contradict its observed antioxidant effect. However, we did find that curcumin at higher doses did cause oxidative DNA damage. Consequently, curcumin has both pro- and antioxidative effect according to doses.
Thus, it is important to know the concentration of the real-life exposure. Curcumin exhibits low oral bioavailability in rodents, and absorbed curcumin undergoes rapid first-pass metabolism and excretion in the bile (Sharma et al., 2005). In a clinical study of high-dose oral curcumin performed by Cheng et al. (2001), the 8-g/day dose resulted in a peak serum concentration of 1.77 ± 1.87µM. In another study, coadministration of piperine, primarily found in the fruit of the pepper vine Piper nigrum and also found in other vegetables and spices such as hot jalapeno peppers, may increase the systemic bioavailability of curcumin (Shoba et al., 1998). In the same study, coingestion of curcumin with 20 mg of the pepper constituent 1-piperoylpiperidine appeared to increase curcumin's bioavailability by 2000%. Combining the data from the two studies, the peak serum concentration of curcumin may be about 35.4µM (about 13 µg/ml). Also, although curcumin was rapidly biotransformed, the metabolites may retain the pharmacologic properties of curcumin. So the relatively low concentrations of curcumin in serum or tissues may not necessarily reflect the total biologic activity of oral curcumin. All these data indicate that the effect of DNA damage we observed in vitro could occur in vivo. Consuming high doses of curcumin should be avoided, and the coingestion of piperine-containing foods with curcumin should be limited.
In summary, the findings of the DNA damage induced by curcumin in a dose-dependent manner lead us to hypothesize that curcumin may play a dual role in carcinogenesis. The extensive curcumin-induced mtDNA damage shed light on a possible additional mechanism of cytotoxicity by curcumin. It is very important to establish the circumstances of the oxidative mode of curcumin, and the bioactivities of curcumin at low dose need further study.
|
SUPPLEMENTARY DATA |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONSUPPLEMENTARY DATAREFERENCES |
|---|
Supplementary data are available online at http://toxsci.oxfordjournals.org/.
|
ACKNOWLEDGMENTS |
|---|
This work was supported by Central Laboratory of Dalian Medical University for Instrumental Assistance. We thank Dr. Anne M. Hutson from the Department of Pediatrics–Gastroenterology, Hepatology and Nutrition, Texas Children's Hospital, Baylor College of Medicine, for language correction of the manuscript.
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONSUPPLEMENTARY DATAREFERENCES |
|---|
Ammon, H. P., and Wahl, M. A. (1991). Pharmacology of Curcuma longa. Planta Med. 57, 1–7.[ISI][Medline]
Bandy, B., and Davison, A. J. (1990). Mitochondrial mutations may increase oxidative stress: Implications for carcinogenesis and aging? Free Radic. Biol. Med. 8, 523–539.[CrossRef][ISI][Medline]
Blasiak, J., Trzeciak, A., Malecka-Panas, E., Drzewoski, J., Iwanienko, T., Szumiel, I., and Wojewodzka, M. (1999). DNA damage and repair in human lymphocytes and gastric mucosa cells exposed to chromium and curcumin. Teratog. Carcinog. Mutagen. 19, 19–31.[CrossRef][ISI][Medline]
Chan, W. H., Wu, H. J., and Hsuuw, Y. D. (2005). Curcumin inhibits ROS formation and apoptosis in methylglyoxal-treated human hepatoma G2 cells. Ann. N.Y. Acad. Sci. 1042, 372–378.
Cheng, A. L., Hsu, C. H., Lin, J. K., Hsu, M. M., Ho, Y. F., Shen, T. S., Ko, J. Y., Lin, J. T., Lin, B. R., Wu, M. S., et al. (2001). Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 21, 2895–2900.[ISI][Medline]
Croteau, D. L., Stierum, R. H., and Bohr, L. A. (1999). Mitochondrial DNA repair pathways. Mutat. Res. 434, 137–148.[ISI][Medline]
Greenlee, R. T., Murray, R., Bolden, S., and Wingo, P. A. (2000). Cancer statistics, 2000. CA Cancer J. Clin. 50, 7–33.[Abstract]
Hayakava, M., Hattori, K., Sugiyama, S., and Ozawa, T. (1992). Age-associated oxygen damage and mutations in mitochondrial DNA in human heart. Biochem. Biophys. Res. Commun. 189, 979–985.[CrossRef][ISI][Medline]
Hruazkewycz, A. M. (1988). Evidence for mitochondrial DNA damage by lipid peroxidation. Biochem. Biophys. Res. Commun. 153, 191–197.[CrossRef][ISI][Medline]
Jobin, C., Bradham, C. A., Russo, M. P., Juma, B., Narula, A. S., Brenner, D. A., and Sartor, R. B. (1999). Curcumin blocks cytokine-mediated NF-kB activation and proinflammatory gene expression by inhibiting inhibitory factor I-kB kinase activity. J. Immunol. 163, 3474–3483.
Kao, S. H., Choa, H. T., and Wei, Y. H. (1998). Multiple deletions of mitochondrial DNA are associated with the decline of motility and fertility of human spermatozoa. Mol. Hum. Reprod. 4, 657–666.
Kelly, M. R., Xu, J., Alexander, K. E., and Loo, G. (2001). Disparate effects of similar phenolic phytochemicals as inhibitors of oxidative damage to cellular DNA. Mutat. Res. 485, 309–318.[ISI][Medline]
Kuttan, R., Sudheeran, P. C., and Josph, C. D. (1987). Turmeric and curcumin as topical agents in cancer therapy. Tumori 73, 29–31.[ISI][Medline]
Leal, L. K. A. M., Nobre, H. V., Jr., Cunhaa, G. M. A., Moraes, M. O., Pessoa, C., Oliveira, R. A., Silveira, E. R., Canuto, K. M., and Viana, G. S. B. (2005). Amburoside A, a glucoside from Amburana cearensis, protects mesencephalic cells against 6-hydroxydopamine-induced neurotoxicity. Neurosci. Lett. 388, 86–90.[Medline]
Liang, F. Q., and Godley, B. F. (2003). Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: A possible mechanism for RPE aging and age-related macular degeneration. Exp. Eye Res. 76, 397–403.[CrossRef][ISI][Medline]
Linnane, A. W., Marzuki, S., Ozawa, T., and Tanaka, M. (1989). Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet 1, 642–645.[CrossRef][ISI][Medline]
Mandavilli, B. S., Boldogh, I., and Van Houten, B. (2005). 3-Nitropropionic acid-induced H2O2, mitochondrial DNA damage, and cell death are attenuated by Bcl-2 overexpression in PC12 cells. Mol. Brain Res. 133, 215–223.[Medline]
Mersch-Sundermann, V., Knasmuller, S., Wu, X. J., Darroudi, F., and Kassie, F. (2004). Use of a human-derived liver cell line for the detection of cytoprotective, antigenotoxic and cogenotoxic agents. Toxicology 198, 329–340.[Medline]
Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55–63.[CrossRef][ISI][Medline]
Myhre, Andersen, J. M., Aarnes, H., and Fonnum, F. (2003). Evaluation of the probes 2,7-dichlorofluorescin diacetate, luminol, and lucigenin as indicators of reactive species formation. Biochem. Pharmacol. 65, 1575–1582.[CrossRef][ISI][Medline]
Onuki, J., Chen, Y., Teixeira, P. C., Schumacher, R. I., Medeiros, M. H. G., Van Houten, B., and Mascio, P. D. (2004). Mitochondrial and nuclear DNA damage induced by 5-aminolevulinic acid. Arch. Biochem. Biophys. 432, 178–187.[Medline]
Plummer, S. M., Hill, K. A., Festing, M. F. W., Steward, W. P., Gescher, A. J., and Sharma, R. A. (2001). Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agents. Cancer Epidemiol. Biomark Prev. 10, 1295–1299.
Polasa, K., Naidu, A. N., Ravindranath, I., and Krishnaswamy, K. (2004). Inhibition of B(a)P induced strand breaks in presence of curcumin. Mutat. Res. 557, 203–213.[ISI][Medline]
Richter, C. (1995). Oxidative damage to mitochondrial DNA and its relationship to ageing. Int. J. Biochem. Cell Biol. 27, 647–653.[CrossRef][ISI][Medline]
Sassa, S., Sugita, O., Galbraith, R. A., and Kappas, A. (1987). Drug metabolism by the human hepatoma cell, Hep-G2. Biochem. Biophys. Res. Commun. 143, 52–57.[CrossRef][Medline]
Sharma, R. A., Gescher, A. J., and Steward, W. P. (2005). Curcumin: The story so far. Eur. J. Cancer 41, 1955–1968.[CrossRef][ISI][Medline]
Sharma, R. A., Ireson, C. R., Verschoyle, R. D., Hill, K. A., Williams, M. L., Leuratti, C., Manson, M. M., Marnett, L. J., Steward, W. P., and Gescher, A. J. (2001). Effects of dietary curcumin on glutathione s-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: Relationship with drug levels. Clin. Cancer Res. 7, 1452–1458.
Shoba, G., Joy, D., Joseph, T., Majeed, M., Rajendran, R., and Srinivas, P. S. (1998). Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 64, 353–356.[ISI][Medline]
Shoffner, J. M., and Wallace, D. D. (1994). Oxidative-phosphorylation diseases and mitochondrial-DNA mutations—Diagnosis and treatment. Annu. Rev. Nutr. 14, 535–568.[CrossRef][ISI][Medline]
Singh, N. P., and Stephens, R. E. (1997). Microgel electrophoresis: Sensitivity, mechanisms, and DNA electrostretching. Mutat. Res. 383, 167–175.[ISI][Medline]
Sohn, J. H., Han, K. L., Lee, S. H., and Hwang, J. K. (2005). Protective effects of panduratin A against oxidative damage of tert-butylhydroperoxide in human HepG2 cells. Biol. Pharm. Bull. 28, 1083–1086.[Medline]
Tattersall, M. H. N., and Thomas, H. (1999). Recent advances: Oncology. Br. Med. J. 318, 445–448.
Uhl, M., Helma, C., and Knasmuller, S. (2000). Evaluation of the single cell gel electrophoresis assay with human hepatoma (Hep G2) cells. Mutat. Res. 468, 213–225.[ISI][Medline]
Velsor, L. W., Kovacevic, M., Goldstein, M., Leitner, H. M., Lewis, W., and Day, B. J. (2004). Mitochondrial oxidative stress in human hepatoma cells exposed to stavudine. Toxicol. Appl. Pharmacol. 199, 10–19.[CrossRef][Medline]
Xu, A., Wu, L. J., Santella, R. M., and Hei, T. K. (1999). Role of oxyradicals in mutagenicity and DNA damage induced by crocidolite asbestos in mammalian cells. Cancer Res. 59, 5922–5926.
Yakes, F. M., Chen, Y., and Van Houten, B. (1996). PCR-based assays for the detection and quantitation of DNA damage and repair. In Technologies for Detection of DNA Damage and Mutations (G. P. Pfeifer, Ed.), pp. 169–182. Plenum Press, New York.
Yakes, F. M., and Van Houten, B. (1997). Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 94, 514–519.
Yarborough, A., Zhang, Y. J., Hsu, T. M., and Santella, R. M. (1996). Immunoperoxidase detection of 8-hydroxydeoxyguanosine in aflatoxin B1-treated rat liver and human oral mucosal cells. Cancer Res. 56, 683–688.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. Tan, D. S. Goerlitz, R. G. Dumitrescu, D. Han, F. Seillier-Moiseiwitsch, S. M. Spernak, R. A. Orden, J. Chen, R. Goldman, and P. G. Shields Associations between cigarette smoking and mitochondrial DNA abnormalities in buccal cells Carcinogenesis, June 1, 2008; 29(6): 1170 - 1177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. R. Wasson, V. J. McKelvey-Martin, and C. S. Downes The use of the comet assay in the study of human nutrition and cancer Mutagenesis, May 1, 2008; 23(3): 153 - 162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Cui, J. Miao, and L. Cui Cytotoxic Effect of Curcumin on Malaria Parasite Plasmodium falciparum: Inhibition of Histone Acetylation and Generation of Reactive Oxygen Species Antimicrob. Agents Chemother., February 1, 2007; 51(2): 488 - 494. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||